Target Benefits Provitalize targets bloating, energy, body composition, inflammation, and the symptoms that tend to show up together during midlife
Watch the full webinar, "Will GLP-1s Ease or Escalate Health Care Costs?" above
Menopause: Nutrition and Weight Gain About SWAN: Study of Womens Health Across the Nation (2019)
How is it that the taxpayers who funded the foundational scientific research that motivated the discovery are now charged 510x more for the same medication
Efficient, respectful service
This superior efficacy helped it achieve global sales of ~US$16.4bn in 2024 (Mounjaro ~US$11.5bn and Zepbound ~US$4.9bn), rivalling semaglutide and completely overshadowing the sales of historical GLP-1s, such as exenatide, liraglutide and dulaglutide [FIGURE TWO]